BIRB796 is a protein kinase inhibitor of p38 MAPK. BIRB796 has high picomolar affinity for p38 MAP kinase and low nanomolar inhibitory activity against TNF-alpha in THP-1 cell culture. The p38 inhibitor BIRB796 binds tightly to ABL(T315I) and inhibits the BMS-354825 and imatinib-resistant ABL(T315I) kinase. BIRB796 has been used as part of the naive human stem cell (NSHM) medium to create naive state human cells.
Peptides & proteins
Doramapimod, BIRB-796, BIRB 796, 285983-48-4, S1574_Selleck, Kinome_2137, 1kv2, UNIIHO1A8B3YVV, Doramapimod (USAN/INN), 1-(5-tertButyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4- yl-ethoxy)naphthalen-1-yl]urea
1) Gafni, O., et al. 2013. Nature. 504(7479): 282-286. PMID: 24172903
-20°C. Keep away from direct sunlight.
12 months from receipt